BioVoice News November 2017 Issue 6 Volume 2 | Page 22

about the 3D implants and what are you doing to create the awareness among your target audience? The awareness levels are very low when it comes to the use of 3D printing in medical practices in India. Our strategy is to build relationships with relevant stakeholders by attending the conferences of importance, one on one meetings with clinical innovators enthusiastic about new developments in 3D printing. They will be our champions of knowledge as they will use it and gain the first hand experience followed by spreading the word around. It is going to take time as the global innovations will spread slowly. The doctors from India will come to know about these through social media and other mediums as well. They will travel to various other countries 22 BioVoiceNews | November 2017 “ Having established the Asian headquarters at Singapore, we now plan to build our operations in India and other countries in Asia.” curve for them but it is a matter of time, that they will create unique products. But at this moment, we have an edge due to the long experience we have in this space. We have our own softwares to design and test various aspects related to the implants. These are extremely complex processes and those will take time. What I have seen happening in India are the and gain knowledge first patient centric anatomy hand. I guess things will models that are used for pick up in next couple of pre-surgery planning. The years. doctors would be interested in the real time What is the current use of 3D printing in models where they could actually understand the medical implants issues in patients. I have within India? seen such anatomy models being used but it is a drop In India, the usage is in the ocean. So, that is the limited as of now. There are only few startups who low hanging fruit where have been working on the we could witness more 3D printed products. Very companies venturing into new and yet to build upon the area. But the surgery and implants would their capability to manufacture implants that require more capabilities and intellectual property. are safe. It is a learning